Chief Executive Offier, Philipp Mathieu, buys Immunovia warrants
LUND (SWEDEN) – Immunovia AB (Nasdaq: IMMNOV) announces today that Philipp Mathieu, CEO of Immunovia, has purchased 150000 warrants of the 2022/2026 scheme for approximately 297 KSEK. His total holding now amounts to 2108 shares and 250 000 warrants in Immunovia. The warrants have a subscription price per share of SEK 88.69. Other management team members have subscribed for 100 000 warrants of the same scheme. For more information, please contact:Karin Almqvist Liwendahl CFOkain.almqvist.liwendahl@immunovia.com+46 70 911 56 08 About Immunovia